← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

M 10b5-1 Plan

$ Value

$169K

Shares

24,611

Price

$7

Filed

Aug 14

Insider

Name

Smith Hunter C

Title

Chief Financial Officer

CIK

0001636385

Roles

Officer

Transaction Details

Transaction Date

2025-08-12

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

141,526

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. | The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $96.00 to $96.63 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The stock option is fully vested.

Filing Info

Accession No.

0001104659-25-078815

Form Type

4

Issuer CIK

0001649904

Smith Hunter C's History

Date Ticker Type Value
2026-02-05 RYTM $359K
2026-02-04 RYTM $157K
2026-02-04 RYTM $107K
2026-02-04 RYTM $80K
2026-02-01 RYTM M
2026-02-01 RYTM F $1.2M
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-01
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-01
Smith Hunter C
Chief Financial Officer
$703K 2026-02-05
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-01
Cramer Pamela J.
Chief Human Resources Officer
2026-02-01
Shulman Joseph
Chief Technical Officer
2026-02-01
Garfield Alastair
Chief Scientific Officer
2026-02-01